Human IGF-1 Receptor / IGF1R Reporter Cell Line – Hep3B

Frequently Asked Questions

• What is the purpose of using IGF1R-Luciferase Reporter Cell Line - Hep3B?

  The IGF1R-Luciferase Reporter Cell Line – Hep3B is designed to study the interaction between IGF-1 and its receptor, IGF-1R. The cell line expresses the IGF-1R receptor and a luciferase reporter gene, which generates a luminescent signal upon stimulation with human IGF-1 protein.

• What is the source and growth pattern of the Hep3B IGF1R-Luciferase Reporter Cell Line?

  The Hep3B IGF1R-Luciferase Reporter Cell Line is derived from human liver cancer cells (Hep3B). It is an adherent cell line.

• What is the typical experimental workflow when using the Hep3B IGF1R Reporter Cell Line?

  The experimental workflow typically includes the following steps:
  1. Culture cells, Monoclonal pre-experimentation
  2. Construction of IGF1R overexpression vectors, construction of response element-luc vectors
  3. Cell transfection, Antibiotic selection
  4. Polyclonal Cell Assay
  5. Flow sorting of monoclonal cells, monoclonal culture
  6. Monoclonal Assay and amplification

• What culture conditions are required for the Hep3B IGF1R-Luciferase Reporter Cell Line?

  The Hep3B IGF1R-Luciferase Reporter Cell Line should be grown under standard conditions suitable for adherent cell lines. The recommended medium is typically supplemented with serum and antibiotics, and cells are maintained in a 37°C incubator with a 5% CO₂ atmosphere.

• What quality control measures are in place for the Hep3B IGF1R-Luciferase Reporter Cell Line?

  The Hep3B IGF1R-Luciferase Reporter Cell Line undergoes stringent quality control processes, including testing for cell viability, sterility, and the absence of contaminants such as mycoplasma, bacteria, and fungi.